The Indian Council of Medical Research (ICMR) is surveying its COVID-19 treatment rules. The wellbeing authority may drop hydroxychloroquine, prevalently called HCQ, from the convention because of expanding question over its viability, The Economic Times has revealed.

The report recommends that ICMR is probably going to incorporate HIV blend medications and FDA-endorsed Ivermectin alongside enhancements of zinc and Vitamin C to improve resistance and perhaps diminish viral replication, in the changed convention.

The Health research office is likewise intending to lead a preliminary on HCQ's adequacy, the report included.

"The malady is advancing and since we realize that HCQ isn't working, it ought to be expelled from the treatment convention," an individual acquainted with the improvement told the paper. "Or maybe different medications which have end up being solid ought to be included into the new convention."

A few microbiologists have contradicted the utilization of HCQ for COVID-19 treatment.

In spite of these clinical alerts about the utilization of the intestinal sickness medicate, US President Donald Trump on May 18 said he is taking HCQ as preventive medication against COVID-19, an illness brought about by the novel coronavirus.

"I'm taking hydroxychloroquine," Trump said. "I've been taking it for the most recent week and a half. A pill consistently."